Abstract: The present invention relates to PD-0184264 for use in a method for the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza vims infection or a viral or bacterial infection alone. Also provided are compositions comprising such inhibitors for use in the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial or viral infection alone.

Abstract: The present invention relates to MEK inhibitors for use in a method for the treatment of a coronavirus infection and/or the treatment or prevention of COVID-19 cytokine storm. Also provided are compositions comprising such inhibitors for use in the treatment of a corona virus infection, such as COVID-19.

Abstract: A method is provided for determining a position of a mobile participant of a wireless communication network, wherein the method comprises: determining (102) a first distance between the mobile participant and a stationary participant of the wireless communication network depending on a location signal transmitted by the stationary participant or the mobile participant; determining (104) a second distance between a stationary replicator unit and the mobile participant depending on a replicated signal which is transmitted by means of the stationary replicator unit depending on the location signal, and depending on a further distance between the replicator unit and the stationary participant; and determining (106) a position of the mobile participant depending on the first distance and depending on the second distance.

Abstract: The present invention relates to RSK inhibitors that are capable of displaying one or more beneficial therapeutic effects. The RSK inhibitors can be used in the prevention and/or treatment of viral infection. RSK inhibitors alone or in combination with other anti-viral inhibitor compounds are capable of displaying one or more beneficial therapeutic effects in the treatment of viral diseases.

Abstract: The present invention relates to MEK inhibitor, p38 inhibitor and/or NF?B inhibitor for use in a method for the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial infection alone. Also provided are compositions comprising such inhibitors for use in the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial infection alone. In addition an in vitro test system, wherein the test system comprises cultured cells infected with an influenza virus and a bacterium or with a bacterium alone is provided.

Abstract: A method is provided for determining a position of a mobile participant of a wireless communication network, wherein the method comprises: determining (102) a first distance between the mobile participant and a stationary participant of the wireless communication network depending on a location signal transmitted by the stationary participant or the mobile participant; determining (104) a second distance between a stationary replicator unit and the mobile participant depending on a replicated signal which is transmitted by means of the stationary replicator unit depending on the location signal, and depending on a further distance between the replicator unit and the stationary participant; and determining (106) a position of the mobile participant depending on the first distance and depending on the second distance.

Abstract: The present invention relates to MEK inhibitor, p38 inhibitor and/or NF?B inhibitor for use in a method for the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial infection alone. Also provided are compositions comprising such inhibitors for use in the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial infection alone. In addition an in vitro test system, wherein the test system comprises cultured cells infected with an influenza virus and a bacterium or with a bacterium alone is provided.

Abstract: The present invention relates to PD-0184264 for use in a method for the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza vims infection or a viral or bacterial infection alone. Also provided are compositions comprising such inhibitors for use in the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial or viral infection alone.

Abstract: The present invention relates to MEK inhibitor, p38 inhibitor and/or NF?B inhibitor for use in a method for the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial infection alone. Also provided are compositions comprising such inhibitors for use in the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial infection alone. In addition an in vitro test system, wherein the test system comprises cultured cells infected with an influenza virus and a bacterium or with a bacterium alone is provided.

Abstract: A method for evaluating radar radiation. A plurality of radar waves are received, and respective individual measured signals are outputted in a complex form. A total measured signal is ascertained and outputted by respective weighted summation of at least one product of each individual measured signal times a respective conjugatedly complex individual measured signal.

Abstract: The present invention relates to MEK inhibitor, p38 inhibitor and/or NF?B inhibitor for use in a method for the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial infection alone. Also provided are compositions comprising such inhibitors for use in the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial infection alone. In addition an in vitro test system, wherein the test system comprises cultured cells infected with an influenza virus and a bacterium or with a bacterium alone is provided.

Abstract: A method for generating a cryptographic key, wherein a first node transmits a first signal on a first channel to a relay, a second node transmits a second signal on a second channel to the relay, the first node receives a third signal from the relay on the first channel and a fourth signal derived at least from the first signal and from the second signal, the second node receives the third signal and the fourth signal from the relay on the second channel, the first node determines the key based on the first signal, on the third signal and on the fourth signal and the second node determines the key based on the second signal, on the third signal and on the fourth signal.

Abstract: A method for generating a shared secret between a first user and a second user of a network is provided. The first user receives from the second user a first training sequence via a communication link between the first user and the second user. The first user ascertains at least one first value for at least one physical property of the communication link, and determines a portion of the shared secret as a function of the first value. A comparison of the first value to at least one threshold takes place for determining the portion of the shared secret. The first user transmits the first training sequence to the second user via the communication link, and adapts the transmission parameters of the first training sequence as a function of the position of the first value relative to the threshold.

Abstract: A method for generating a cryptographic key, wherein a first node transmits a first signal on a first channel to a relay, a second node transmits a second signal on a second channel to the relay, the first node receives a third signal from the relay on the first channel and a fourth signal derived at least from the first signal and from the second signal, the second node receives the third signal and the fourth signal from the relay on the second channel, the first node determines the key based on the first signal, on the third signal and on the fourth signal and the second node determines the key based on the second signal, on the third signal and on the fourth signal.

Abstract: A method for evaluating radar radiation. A plurality of radar waves are received, and respective individual measured signals are outputted in a complex form. A total measured signal is ascertained and outputted by respective weighted summation of at least one product of each individual measured signal times a respective conjugatedly complex individual measured signal.

Abstract: The present invention relates to MEK inhibitors that are capable of displaying one or more beneficial therapeutic effects. The MEK inhibitors can be used in the prevention and/or treatment of viral infection. MEK inhibitors in combination with neuraminidase inhibitor compounds are capable of displaying one or more beneficial therapeutic effects in the treatment of viral diseases.

Abstract: The invention provides a combination of an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 1 or a homolog thereof, and an isolated peptide or peptidomimetic that includes the sequence of SEQ ID NO: 2. The invention also provides a method of treating a BCR-ABL associated disease or a c-ABL associated disease in a subject. The method is based on the use of the aforementioned combination of one or more isolated peptides or peptidomimetics.

Abstract: The present invention relates to MEK inhibitor, p38 inhibitor and/or NF?B inhibitor for use in a method for the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial infection alone. Also provided are compositions comprising such inhibitors for use in the prophylaxis and/or treatment of a co-infection comprising a bacterial infection and an influenza virus infection or a bacterial infection alone. In addition an in vitro test system, wherein the test system comprises cultured cells infected with an influenza virus and a bacterium or with a bacterium alone is provided.

Abstract: A method for generating a shared secret between a first user and a second user of a network is provided. The first user receives from the second user a first training sequence via a communication link between the first user and the second user. The first user ascertains at least one first value for at least one physical property of the communication link, and determines a portion of the shared secret as a function of the first value. A comparison of the first value to at least one threshold takes place for determining the portion of the shared secret. The first user transmits the first training sequence to the second user via the communication link, and adapts the transmission parameters of the first training sequence as a function of the position of the first value relative to the threshold.

Abstract: The present invention relates to MEK inhibitors that are capable of displaying one or more beneficial therapeutic effects. The MEK inhibitors can be used in the prevention and/or treatment of viral infection. MEK inhibitors in combination with neuraminidase inhibitor compounds are capable of displaying one or more beneficial therapeutic effects in the treatment of viral diseases.